NCT05023954

Brief Summary

A prospective observational cohort study investigating physiological parameters vs biological markers of whole blood in septic and non-septic pregnant woman to predict systemic immune health

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
330

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 12, 2020

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

August 10, 2021

Completed
17 days until next milestone

First Posted

Study publicly available on registry

August 27, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2022

Completed
Last Updated

August 27, 2021

Status Verified

August 1, 2021

Enrollment Period

1.5 years

First QC Date

August 10, 2021

Last Update Submit

August 20, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Positive predictive value of genomic sepsis-test biomarker in identifying participants with confirmed sepsis

    New genomic sepsis-test biomarker tested to see if it compares to clinically known biomarkers in identifying sepsis

    2 years

Study Arms (2)

A

A longitudinal observational study looking at the pregnancy journey of 200 women Bloods taken for sepsis biomarkers including a genomic sepsis-test throughout the pregnancy journey

Diagnostic Test: Blood test

B

A consecutive collection of data from 100 pregnant women with suspected sepsis Bloods taken for Sepsis Biomarkers including a genomic sepsis-test throughout the sepsis episode

Diagnostic Test: Blood test

Interventions

Blood testDIAGNOSTIC_TEST

Drop of blood for RNA and metabolic analysis

AB

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPregnant Participants
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Pregnant women attending University Hospital of Wales Cardiff for their pregnancy care

You may qualify if:

  • Pregnant with viable pregnancy confirmed on ultrasound at dating scan and over 18 years of age Able to provide informed consent (a translation service will be provided for women where English is not the first language);
  • Women recruited into Cohort B will have deferred consent taken to avoid interference with clinical care.

You may not qualify if:

  • Pregnant woman under the age of 18 or wishing not to consent, withdrawing consent or lacking capacity.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sir Geraint Evans, Cardiff University

Cardiff, CF14 4ED, United Kingdom

RECRUITING

Related Publications (1)

  • Sharma S, Zaher S, Rodrigues PRS, Davies LC, Edkins S, Strang A, Chakraborty M, Watkins WJ, Andrews R, Parkinson E, Angelopoulos N, Moet L, Shepherd F, Davies KMM, White D, Oram S, Siddall K, Keeping V, Simpson K, Faggian F, Bray M, Bertorelli C, Bell S, Collis RE, McLaren JE, Labeta M, O'Donnell VB, Ghazal P. mSep: investigating physiological and immune-metabolic biomarkers in septic and healthy pregnant women to predict feto-maternal immune health - a prospective observational cohort study protocol. BMJ Open. 2022 Sep 17;12(9):e066382. doi: 10.1136/bmjopen-2022-066382.

Biospecimen

Retention: SAMPLES WITHOUT DNA

RNA analysis

MeSH Terms

Conditions

SepsisPregnancy Complications, Infectious

Interventions

Hematologic Tests

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

Clinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisInvestigative Techniques

Study Officials

  • Peter Ghazal, PHD

    Cardiff University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Simran Sharma, MBBCH

CONTACT

Summia Zaher, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 10, 2021

First Posted

August 27, 2021

Study Start

October 12, 2020

Primary Completion

April 1, 2022

Study Completion

September 1, 2022

Last Updated

August 27, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Locations